Preclinical Research on GHK-Cu and Cellular Regeneration Preclinical research on GHK-Cu explores fibroblasts, collagen, glycosaminoglycans, angiogenesis, inflammation, matrix metalloproteinases, tissue inhibitors, and wound models [4], [5], [10], [12]
Less common systemic effects that some users report include mild dizziness or lightheadedness, temporary nausea, mild headache, and occasional fatigue
[PMID: 24889263] PubMed record related to this compound for laboratory literature review
Analogous metabolic alterations found in patients on an FMD during estrogen therapy suggest the potential of diet as an adjuvant in treating hormone receptor-positive breast cancer
In addition, 48% were Caucasian, 36% were Asian, 8% were Hispanic, and 8% were African-American